well health technologies corp - WHTCF

WHTCF

Close Chg Chg %
2.81 -0.06 -2.17%

Closed Market

2.75

-0.06 (2.17%)

Volume: 15.35K

Last Updated:

Apr 7, 2026, 3:58 PM EDT

Company Overview: well health technologies corp - WHTCF

WHTCF Key Data

Open

$2.74

Day Range

2.74 - 2.75

52 Week Range

2.61 - 4.31

Market Cap

$702.53M

Shares Outstanding

255.47M

Public Float

197.09M

Beta

1.38

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.02

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

90.81K

 

WHTCF Performance

1 Week
 
-1.82%
 
1 Month
 
-14.63%
 
3 Months
 
-9.87%
 
1 Year
 
-10.46%
 
5 Years
 
-55.78%
 

WHTCF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About well health technologies corp - WHTCF

WELL Health Technologies Corp. operates as digital healthcare company, which engages in owning and operating a portfolio of primary healthcare facilities. Its virtual services includes telehealth, electronic medical record, patien portal, ePharmacy, billing and RCM, cybersecurity, and digital apps.. The company was founded by Hamed Shahbazi on November 23, 2010 and is headquartered in Vancouver, Canada.

WHTCF At a Glance

WELL Health Technologies Corp.
375 Water Street
Vancouver, British Columbia V6B 5C6
Phone 1-604-628-7266 Revenue 1.00B
Industry Medical/Nursing Services Net Income -5,267,344.33
Sector Health Services 2025 Sales Growth 49.268%
Fiscal Year-end 12 / 2026 Employees N/A
View SEC Filings

WHTCF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.734
Price to Book Ratio 1.174
Price to Cash Flow Ratio 8.88
Enterprise Value to EBITDA 8.684
Enterprise Value to Sales 1.283
Total Debt to Enterprise Value 0.404

WHTCF Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 6.779
Total Asset Turnover 0.719

WHTCF Liquidity

Current Ratio 1.034
Quick Ratio 1.027
Cash Ratio 0.374

WHTCF Profitability

Gross Margin 37.501
Operating Margin 8.073
Pretax Margin 0.575
Net Margin -0.526
Return on Assets -0.378
Return on Equity -0.854
Return on Total Capital -0.459
Return on Invested Capital -0.532

WHTCF Capital Structure

Total Debt to Total Equity 82.334
Total Debt to Total Capital 45.156
Total Debt to Total Assets 33.906
Long-Term Debt to Equity 69.639
Long-Term Debt to Total Capital 38.193
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Well Health Technologies Corp - WHTCF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
437.17M 574.99M 671.32M 1.00B
Sales Growth
+81.30% +31.52% +16.75% +49.27%
Cost of Goods Sold (COGS) incl D&A
246.61M 344.19M 459.12M 626.28M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
42.40M 45.02M 52.78M 67.10M
Depreciation
9.51M 11.16M 16.14M 20.42M
Amortization of Intangibles
32.89M 33.86M 36.64M 46.69M
COGS Growth
+65.47% +39.57% +33.39% +36.41%
Gross Income
190.57M 230.79M 212.20M 375.79M
Gross Income Growth
+106.89% +21.11% -8.06% +77.09%
Gross Profit Margin
+43.59% +40.14% +31.61% +37.50%
2022 2023 2024 2025 5-year trend
SG&A Expense
170.23M 200.34M 226.33M 294.89M
Research & Development
- - - -
-
Other SG&A
170.23M 200.34M 226.33M 294.89M
SGA Growth
+72.78% +17.69% +12.98% +30.29%
Other Operating Expense
- - - -
-
Unusual Expense
(10.41M) (10.79M) (60.31M) 40.84M
EBIT after Unusual Expense
30.75M 41.25M 46.18M 40.05M
Non Operating Income/Expense
578.41K (2.57M) (9.52M) 4.70M
Non-Operating Interest Income
498.52K 565.32K 928.49K 1.23M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
17.56M 23.95M 26.92M 38.99M
Interest Expense Growth
+144.86% +36.35% +12.42% +44.81%
Gross Interest Expense
17.56M 23.95M 26.92M 38.99M
Interest Capitalized
- - - -
-
Pretax Income
13.77M 14.73M 9.73M 5.77M
Pretax Income Growth
+169.69% +6.97% -33.91% -40.75%
Pretax Margin
+3.15% +2.56% +1.45% +0.58%
Income Tax
(883.36K) 2.12M (14.67M) 605.46K
Income Tax - Current - Domestic
2.21M 9.40M 6.74M 14.50M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(3.10M) (7.28M) (21.41M) (13.89M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
14.34M 12.33M 21.24M 3.19M
Minority Interest Expense
13.29M 12.27M (2.56M) 8.46M
Net Income
1.05M 60.75K 23.80M (5.27M)
Net Income Growth
+103.01% -94.22% +39,078.54% -122.13%
Net Margin Growth
+0.24% +0.01% +3.55% -0.53%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
1.05M 60.75K 23.80M (5.27M)
Preferred Dividends
- - - -
-
Net Income Available to Common
1.05M 60.75K 23.80M (5.27M)
EPS (Basic)
0.0048 0.0003 0.0965 -0.0208
EPS (Basic) Growth
+102.62% -93.75% +32,066.67% -121.55%
Basic Shares Outstanding
220.69M 236.54M 246.76M 252.80M
EPS (Diluted)
0.0048 0.0003 0.0935 -0.0208
EPS (Diluted) Growth
+102.62% -93.75% +31,066.67% -122.25%
Diluted Shares Outstanding
220.69M 236.54M 254.65M 252.80M
EBITDA
62.74M 75.48M 38.64M 148.00M
EBITDA Growth
+160.70% +20.31% -48.80% +282.96%
EBITDA Margin
+14.35% +13.13% +5.76% +14.77%

Well Health Technologies Corp in the News